[There were two candidates for the title of this post. I gave you both. Let me know which one you like better.]

This week, Congress overrode the President’s veto of H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008, making it Public Law number 110-275.

The 100+ page law does lots of things, including especially extending expiring provisions under the Medicare Program. But the good folks at SNM want you to know something extra-special about it: The law includes an 18-month extension of the 2007 reimbursement rates for radioimmunotherapies! Hey, hey! Now that’s somethin’!

I guess . . .

SNM is not what you might have thought at first. It’s “an international scientific and medical organization dedicated to raising public awareness about what molecular imaging.” And they want you to know how pleased they are about the radiopharmaceuticals continuing to be reimbursed under Medicare. Radiopharmaceuticals are used in the field of nuclear medicine as tracers in the diagnosis and treatment of cancer, neurological disease, and many other types of debilitating and life-threatening illness.

So it’s a happy day for SNM. We can all get our radiopharmaceuticals now!